Adaptive Biotechnologies (ADPT) Insider Trading & Ownership

$4.65

-0.13 (-2.72%)

(As of 09/20/2024 ET)

Current Insider Ownership Percentage: 6.20%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 5
Amount Of Insider Selling (Last 12 Months): $429,160.04

Get ADPT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Adaptive Biotechnologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ADPT Insider Buying and Selling by Quarter

Ad Weiss Ratings

The #1 Crypto for AI

We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”

Learn more about it by watching THIS NOW.

Adaptive Biotechnologies Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
3/5/2024	Chad M Robins	CEO	Sell	48,673	$3.43	$166,948.39
3/5/2024	Julie Rubinstein	President	Sell	39,070	$3.47	$135,572.90
3/5/2024	Kyle Piskel	Insider	Sell	7,727	$3.43	$26,503.61
3/5/2024	Stacy L Taylor	SVP	Sell	13,381	$3.43	$45,896.83
3/5/2024	Tycho Peterson	CFO	Sell	15,456	$3.44	$53,168.64
11/16/2023	Kyle Piskel	Insider	Sell	259	$4.13	$1,069.67

(Data available from 1/1/2013 forward)

ADPT Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Adaptive Biotechnologies includes Chad M Cohen, Chad M Robins, Harlan S Robins, Julie Rubinstein, Kyle Piskel, Lance Baldo, Michelle Renee Griffin, Nitin Sood, R Mark Adams, Stacy L Taylor, and Tycho Peterson. Learn more on insiders at ADPT.
: 6.20% of Adaptive Biotechnologies stock is owned by insiders. Learn more on ADPT's insider holdings.
: The following insiders have sold ADPT shares in the last 24 months: Chad M Robins ($166,948.39), Julie Rubinstein ($329,837.66), Kyle Piskel ($66,323.14), Michelle Renee Griffin ($19,875.09), Nitin Sood ($286,848.56), R Mark Adams ($94,040.46), Stacy L Taylor ($92,954.70), and Tycho Peterson ($2,020,931.18).
: Insiders have sold a total of 450,699 Adaptive Biotechnologies shares in the last 24 months for a total of $3,077,759.18 sold.

Adaptive Biotechnologies Key Executives

Mr. Chad M. Robins M.B.A. (Age 49)
Co-Founder, CEO & Chairman
Compensation: $1M
Ms. Julie Rubinstein (Age 52)
President & COO
Compensation: $721.04k
Dr. Harlan S. Robins Ph.D. (Age 51)
Co-Founder & Chief Scientific Officer
Compensation: $711.09k
Dr. Sharon Benzeno Ph.D. (Age 50)
Chief Commercial Officer of Immune Medicine
Compensation: $630.72k
Mr. Christopher Carlson Ph.D.
Founder
Mr. Kyle Piskel (Age 40)
VP, CFO & Principal Accounting Officer
Compensation: $375.9k
Karina Calzadilla
Vice President of Investor Relations
Ms. Stacy L. Taylor (Age 64)
Senior VP, General Counsel & Corporate Secretary
Mr. Francis T. Lo (Age 43)
Chief People Officer
Ms. Susan Bobulsky (Age 43)
Chief Commercial Officer of MRD